On the basis of these evidences, we investigated the possible role of both Spike-RBD and PF4 proteins and their respective antibodies (Ab) in the etiopathogenesis of thrombosis in COVID-19 severe patients and in vaccinated people experiencing VITT. This evidence concerns the gene PF4 and deep vein thrombosis.